Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学IBD and Cancer Risk, Biologic Therapy

Shomron Ben-Horin

MD

🏢Sheba Medical Center, Tel Aviv University🌐Israel

Professor of Medicine, Head of Gastroenterology

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Shomron Ben-Horin heads gastroenterology at Sheba and is internationally recognized for anti-TNF pharmacokinetics and therapeutic drug monitoring in IBD. He has contributed to safety data on lymphoma and skin cancer risk with thiopurines and biologics. His work informs benefit-risk discussions in IBD therapy.

Share:

🧪Research Fields 研究领域

anti-TNF pharmacokinetics
therapeutic drug monitoring IBD
IBD lymphoma risk
Crohn disease
biosimilar biologics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Shomron Ben-Horin 的研究动态

Follow Shomron Ben-Horin's research updates

留下邮箱,当我们发布与 Shomron Ben-Horin(Sheba Medical Center, Tel Aviv University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment